Tags: Cancer | blood cancer | multiple myeloma | mantle cell lymphoma | myelodysplastic syndromes | Revlimid

New Drug Proves Effective Against Blood Cancer

Thursday, 11 Jul 2013 12:27 PM

 

 
Celgene Corp said a late-stage trial of its cancer drug Revlimid met the main goal of improving survival in newly diagnosed blood cancer patients, potentially opening up the path for a wider use of the drug.

The company's shares were up 4 percent at $129.75 in premarket trade.

Celgene said it will start discussions with regulators and plans to submit applications in the United States, Europe and other markets.

Revlimid is Celgene's flagship blood cancer drug and is already approved for use in previously treated multiple myeloma, mantle cell lymphoma and transfusion-dependent anemia caused by myelodysplastic syndromes - a blood disorder.

The late-stage study tested the oral drug in patients with newly diagnosed multiple myeloma, and showed a statistically significant improvement in survival without the cancer worsening.

Multiple myeloma is the second most commonly diagnosed blood cancer. It starts in the plasma cells in the bone marrow and ultimately disrupts the production of normal blood cells.

The American Cancer Society estimates there will be about 22,350 new cases diagnosed in 2013 and about 10,710 deaths.

The evaluation of safety and efficacy was ongoing and the results will be presented at an upcoming medical meeting, Celgene said.

Revlimid brought in sales of about $1 billion for the first quarter. The approval for mantle cell lymphoma came in early last month.

© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Bacteria Offer New Way to Treat Cancer: M.D. Anderson Study

Sunday, 01 Feb 2015 11:34 AM

Bacteria may offer a new way to treat cancer, a small, preliminary study suggests.

Researchers injected a wea . . .

Do You Get Winter Nose Bleeds? Here's Help

Sunday, 01 Feb 2015 11:29 AM

Nosebleeds are a common during the winter and shouldn't be cause for concern, an expert says.

Cold winter ai . . .

Drug That Fights Binge Eating OKd by FDA

Saturday, 31 Jan 2015 10:04 AM

The U.S. Food and Drug Administration on Friday approved Shire's stimulant Vyvanse to treat binge-eating disorder, the f . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved